New computational model can predict breast cancer survival
Winner of crowd-sourced breast cancer prognosis challenge offers hope for improved diagnosis and prognosis in all cancers
2013-04-18
(Press-News.org) New York, NY—April 17, 2013—Columbia Engineering researchers, led by Dimitris Anastassiou, Charles Batchelor Professor in Electrical Engineering and member of the Columbia Initiative in Systems Biology, have developed a new computational model that is highly predictive of breast cancer survival. The team, who won the Sage Bionetworks / DREAM Breast Cancer Prognosis Challenge for this work, published their results -- "Development of a Prognostic Model for Breast Cancer Survival in an Open Challenge Environment" -- in the April 17 issue of Science Translational Medicine.
In earlier work, Anastassiou and his team had identified what he calls "attractor metagenes," gene signatures that are present in nearly identical form in many cancer types. Working with his PhD students Wei-Yi Cheng and Tai-Hsien Ou Yang, he took these signatures and tested them in the Sage Bionetworks/DREAM Breast Cancer Prognosis Challenge, a crowd-sourced effort for accurate breast cancer prognosis using molecular and clinical data. The team developed a prognostic model that showed that these signatures of cancer, when properly combined, were strong predictors for breast cancer survival.
"These signatures manifest themselves in specific genes that are turned on together in the tissues of some patients in many different cancer types," explains Anastassiou. "And if these general cancer signatures are useful in breast cancer, as we proved in this Challenge, then why not in other types of cancer as well? I think that the most significant—and exciting—implication of our work is the hope that these signatures can be used for improved diagnostic, prognostic, and eventually, therapeutic products, applicable to multiple cancers."
Currently there are already widely used biomarker products that look at specific genes in biopsies of cancer patients, so that doctors can decide if particular treatments are appropriate. "Some of these genes are related to those in our signatures," he says, "so it's worth finding out if replacing such genes with our precise 'pan-cancer' signatures will improve the accuracy of these products."
Anastassiou, who works in systems biology, an emergent interdisciplinary field that focuses on interactions within biological systems, hopes to collaborate with medical researchers studying the biological mechanisms behind these cancer signatures. He thinks of these signatures as "bioinformatic hallmarks of cancer," a term first coined by Jessica Kandel, R. Peter Altman Professor of Surgery and Pediatrics in Columbia's Institute for Cancer Genetics, with whom he collaborates.
"The hallmarks of cancer," he explains, "are unifying biological capabilities present in all cancers, as described in some seminal papers. We think that we have now reached the point where systems biology can also identify such hallmarks."
"We are thrilled that Anastassiou's innovative metagenes approach won the Challenge and is getting the visibility it rightly deserves,” says Stephen H. Friend, president and co-founder, Sage Bionetworks. “Anastassiou's team demonstrated gumption and a thoughtful understanding of what was needed to develop a ‘generalizable’ model that achieved the top CCI score against the newly generated Challenge validation data set."
Anastassiou and his team found the Sage Bionetworks/DREAM Challenge a very productive way to focus on a specific research task. He said that the Challenge provided a vibrant research environment where numerous participants were openly submitting their models and had access to others' models as they were developed. The teams were also encouraged to incorporate the other models into their own. Three hundred fifty-four participants from more than 35 countries registered for the Challenge and submitted more than 1700 models.
The study was funded by the University's allocation for inventor's research—patents from what Anastassiou calls his "previous lifetime," when he was doing research on a totally different topic: digital television. His patents are now used in the international standards for all forms of DVDs including Blu-ray HDTV discs and digital television broadcasting.
###
Columbia Engineering
Columbia University's Fu Foundation School of Engineering and Applied Science, founded in 1864, offers programs in nine departments to both undergraduate and graduate students. With facilities specifically designed and equipped to meet the laboratory and research needs of faculty and students, Columbia Engineering is home to NSF-NIH funded centers in genomic science, molecular nanostructures, materials science, and energy, as well as one of the world's leading programs in financial engineering. These interdisciplinary centers are leading the way in their respective fields while individual groups of engineers and scientists collaborate to solve some of modern society's more difficult challenges. http://www.engineering.columbia.edu/
Media contact:
Holly Evarts
Director of Strategic Communications and Media Relations
212-854-3206 (o) END
ELSE PRESS RELEASES FROM THIS DATE:
2013-04-18
SYDNEY, AUSTRALIA - A team of Australian engineers at the University of New South Wales (UNSW) has demonstrated a quantum bit based on the nucleus of a single atom in silicon, promising dramatic improvements for data processing in ultra-powerful quantum computers of the future.
Quantum bits, or qubits, are the building blocks of quantum computers, which will offer enormous advantages for searching expansive databases, cracking modern encryption, and modelling atomic-scale systems such as biological molecules and drugs.
The world-first result, to be published in Nature ...
2013-04-18
Researchers from the RIKEN Center for Integrative Medical Sciences in Japan report today that they have identified a compound that could be used as a new treatment to prevent relapse in acute myeloid leukemia patients.
In a study published in Science Translational Medicine, they show that this compound reduces the risk of relapse in a mouse model of the human disease. They report that this compound could be most active in patients that carry a mutation lowering their chances of recovery.
Acute myeloid leukemia (AML) is an acute type of blood cancer that starts in the ...
2013-04-18
A key building block in the Schmallenberg virus could be targeted by anti-viral drugs, according to a new study led from the University of Leeds.
The disease, which causes birth defects and stillbirths in sheep, goats and cattle, was first discovered in Germany in late 2011 and has already spread to more than 5,000 farms across Europe, and 1,500 farms in the UK alone.
There is currently no way of treating infected animals, but a study published in Nucleic Acids Research reports that the Schmallenberg virus nucleocapsid protein, which protects its genetic material, could ...
2013-04-18
DURHAM, N.C. -- Close family members of people with Alzheimer's disease are more than twice as likely as those without a family history to develop silent buildup of brain plaques associated with Alzheimer's disease, according to researchers at Duke Medicine.
The study, published online in the journal PLOS ONE on April 17, 2013, confirms earlier findings on a known genetic variation that increases one's risk for Alzheimer's, and raises new questions about other genetic factors involved in the disease that have yet to be identified.
An estimated 25 million people worldwide ...
2013-04-18
An international team of researchers has decoded the genome of a creature whose evolutionary history is both enigmatic and illuminating: the African coelacanth. A sea-cave dwelling, five-foot long fish with limb-like fins, the coelacanth was once thought to be extinct. A living coelacanth was discovered off the African coast in 1938, and since then, questions about these ancient-looking fish – popularly known as "living fossils" – have loomed large. Coelacanths today closely resemble the fossilized skeletons of their more than 300-million-year-old ancestors. Its genome ...
2013-04-18
The European Commission needs to make some key innovations in its science funding programme if Europe is to enjoy the full benefits of the €70 billion to be spent on science research as part of the Horizon 2020 programme kicking off in 2014, according to an academic paper published by SAGE in the Journal of Health Services Research & Policy today.
The Commission has already taken important steps to reduce administration costs and stimulate the participation of small business in research, but there are still significant gaps, say the authors of Europe's 'Horizon 2020' ...
2013-04-18
While studying rats' ability to navigate familiar territory, Johns Hopkins scientists found that one particular brain structure uses remembered spatial information to imagine routes the rats then follow. Their discovery has implications for understanding why damage to that structure, called the hippocampus, disrupts specific types of memory and learning in people with Alzheimer's disease and age-related cognitive decline. And because these mental trajectories guide the rats' behavior, the research model the scientists developed may be useful in future studies on higher-level ...
2013-04-18
Chevy Chase, MD—Reminding primary care doctors to test at-risk patients for osteoporosis can prevent fractures and reduce health care costs, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Osteoporosis is a condition that is common, costly and undertreated. Low trauma fractures in older individuals are a "red flag" for osteoporosis, but those at risk often are not treated for the condition. Rates of osteoporosis testing and treatment are typically less than 20 percent in the first ...
2013-04-18
Chevy Chase, MD––Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Osteoporosis weakens bones and increases the risk patients will suffer fractures. The findings suggest combination therapy may be a more effective approach to battling this common condition.
"The key to effectively treating osteoporosis lies in increasing bone mass," said the study's ...
2013-04-18
Chevy Chase, MD––Hair strands contain valuable information about senior citizens' stress levels that can be used to determine an individual's cardiovascular disease risk, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Unlike a blood test that captures a snapshot of stress hormone levels at a single point in time, a scalp hair analysis can be used to view trends in levels of the stress hormone cortisol over the course of several months. This approach allows researchers to have a better ...
LAST 30 PRESS RELEASES:
[Press-News.org] New computational model can predict breast cancer survival
Winner of crowd-sourced breast cancer prognosis challenge offers hope for improved diagnosis and prognosis in all cancers